Hoth Interest Income from 2010 to 2026

HOTH Stock  USD 0.98  0.04  3.92%   
Hoth Therapeutics' Interest Income is decreasing with slightly volatile movements from year to year. Interest Income is predicted to flatten to 667.76. Interest Income is income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments. View All Fundamentals
 
Interest Income  
First Reported
2010-12-31
Previous Quarter
702.9
Current Value
667.76
Quarterly Volatility
73.6 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Hoth Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Hoth Therapeutics' main balance sheet or income statement drivers, such as Interest Income of 668, Depreciation And Amortization of 9.9 M or Interest Expense of 368.8 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.76. Hoth financial statements analysis is a perfect complement when working with Hoth Therapeutics Valuation or Volatility modules.
  
Build AI portfolio with Hoth Stock
Check out the analysis of Hoth Therapeutics Correlation against competitors.
For more detail on how to invest in Hoth Stock please use our How to Invest in Hoth Therapeutics guide.
The Interest Income trend for Hoth Therapeutics offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Hoth Therapeutics is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.

Latest Hoth Therapeutics' Interest Income Growth Pattern

Below is the plot of the Interest Income of Hoth Therapeutics over the last few years. It is income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments. Hoth Therapeutics' Interest Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Hoth Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Interest Income10 Years Trend
Slightly volatile
   Interest Income   
       Timeline  

Hoth Interest Income Regression Statistics

Arithmetic Mean68,315
Geometric Mean0.00
Coefficient Of Variation107.69
Mean Deviation71,233
Median6,370
Standard Deviation73,567
Sample Variance5.4B
Range144K
R-Value(0.86)
Mean Square Error1.5B
R-Squared0.75
Slope(12,597)
Total Sum of Squares86.6B

Hoth Interest Income History

2026 667.76
2025 702.9
2023 781.0
2022 6370.0
2020null
2018 25.0

Other Fundumenentals of Hoth Therapeutics

Hoth Therapeutics Interest Income component correlations

1.00.93-0.97-0.90.590.910.831.01.01.00.55-0.840.24-0.18-0.71-0.53-0.33
1.00.91-0.97-0.880.530.890.781.01.01.00.56-0.810.27-0.16-0.68-0.51-0.32
0.930.91-0.95-0.970.70.950.870.920.930.920.4-0.790.04-0.4-0.87-0.77-0.58
-0.97-0.97-0.950.93-0.58-0.88-0.82-0.96-0.98-0.97-0.420.76-0.120.330.790.60.38
-0.9-0.88-0.970.93-0.69-0.93-0.84-0.88-0.9-0.89-0.280.820.090.510.930.760.53
0.590.530.7-0.58-0.690.710.880.560.590.560.27-0.75-0.03-0.29-0.62-0.48-0.32
0.910.890.95-0.88-0.930.710.870.890.90.890.5-0.920.12-0.22-0.77-0.69-0.53
0.830.780.87-0.82-0.840.880.870.790.830.80.36-0.860.03-0.22-0.72-0.52-0.3
1.01.00.92-0.96-0.880.560.890.791.01.00.59-0.820.29-0.15-0.68-0.51-0.33
1.01.00.93-0.98-0.90.590.90.831.01.00.53-0.830.22-0.2-0.72-0.54-0.33
1.01.00.92-0.97-0.890.560.890.81.01.00.57-0.810.27-0.16-0.69-0.52-0.33
0.550.560.4-0.42-0.280.270.50.360.590.530.57-0.50.920.560.09-0.07-0.17
-0.84-0.81-0.790.760.82-0.75-0.92-0.86-0.82-0.83-0.81-0.5-0.160.120.630.450.26
0.240.270.04-0.120.09-0.030.120.030.290.220.270.92-0.160.760.440.260.09
-0.18-0.16-0.40.330.51-0.29-0.22-0.22-0.15-0.2-0.160.560.120.760.760.640.46
-0.71-0.68-0.870.790.93-0.62-0.77-0.72-0.68-0.72-0.690.090.630.440.760.820.58
-0.53-0.51-0.770.60.76-0.48-0.69-0.52-0.51-0.54-0.52-0.070.450.260.640.820.94
-0.33-0.32-0.580.380.53-0.32-0.53-0.3-0.33-0.33-0.33-0.170.260.090.460.580.94
Click cells to compare fundamentals

About Hoth Therapeutics Financial Statements

Investors use fundamental indicators, such as Hoth Therapeutics' Interest Income, to determine how well the company is positioned to perform in the future. Although Hoth Therapeutics' investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Interest Income 702.90  667.76 
Net Interest Income 898.15  1,579 

Currently Active Assets on Macroaxis

When determining whether Hoth Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Hoth Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Hoth Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Hoth Therapeutics Stock:
Check out the analysis of Hoth Therapeutics Correlation against competitors.
For more detail on how to invest in Hoth Stock please use our How to Invest in Hoth Therapeutics guide.
You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Is there potential for Pharmaceuticals market expansion? Will Hoth introduce new products? Factors like these will boost the valuation of Hoth Therapeutics. Market participants price Hoth higher when confident in its future expansion prospects. Understanding fair value requires weighing current performance against future potential. All the valuation information about Hoth Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.02)
Return On Assets
(0.84)
Return On Equity
(1.51)
The market value of Hoth Therapeutics is measured differently than its book value, which is the value of Hoth that is recorded on the company's balance sheet. Investors also form their own opinion of Hoth Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Hoth Therapeutics' true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Hoth Therapeutics' market value can be influenced by many factors that don't directly affect Hoth Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Hoth Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Hoth Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Hoth Therapeutics' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.